Despite remarkable progress in pharmaceuticals, more than 7,000 diseases persist without efficacious treatments. Many medical conditions remain underfunded and overlooked, leading to low success rates in new drug discovery endeavors. The journey from identifying a potential molecule to developing a market-ready medicine is an extensive, laborious, and expensive process. However, quantum computing (QC) offers the potential to revolutionize this journey by addressing complex challenges within the healthcare supply chain and even creating new medications from scratch. Nevertheless, the integration of QC into drug research remains a gradual process.